Exploratory performance comparison trial of titanium allergy diagnostic agent
Not Applicable
- Conditions
- Titanium allergy
- Registration Number
- JPRN-UMIN000021240
- Lead Sponsor
- Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects who cannot interrupt the anti-allergic drugs from 3 days before patch test to date ended. 2. Subjects who have used corticosteroid medicine internally and/or externally within 1 month prior to the study. 3. Pregnant women and women of child bearing potential. 4. Subjects who cannot give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive rate, negative rate, safety (rate of irritation response) and specificity to 0.1%, 0.5% titanium sulfate solution, 0.1% titanium chloride solution and oxidized titanium on the 7th day.
- Secondary Outcome Measures
Name Time Method Expression frequency and rate of adverse events